山东医药
山東醫藥
산동의약
SHANDONG MEDICAL JOURNAL
2014年
22期
40-43
,共4页
邱石%苗凤茹%吴涛%李继来%王培福%杜继臣
邱石%苗鳳茹%吳濤%李繼來%王培福%杜繼臣
구석%묘봉여%오도%리계래%왕배복%두계신
阿司匹林%氯吡格雷%血小板抑制率%Meta分析
阿司匹林%氯吡格雷%血小闆抑製率%Meta分析
아사필림%록필격뢰%혈소판억제솔%Meta분석
aspirin%clopidogrel%platelet inhibition rate%Meta analysis
目的:采用Meta分析方法分析阿司匹林、氯吡格雷及两者联合应用抗血小板作用的效果。方法采用Meta分析方法,检索MEDLINE、EMbase、Cochrance临床对照试验资料库、中国生物医学文献数据库、中国学术期刊全文数据库、维普数据库中相关文献,收集所有关于以血栓弹力图评价阿司匹林及氯吡格雷抗血小板作用的研究文献。应用RevMan5.2软件对阿司匹林及氯吡格雷抗血小板作用进行分析。结果共纳入5篇病例对照研究,其中包括阿司匹林组206例,氯吡格雷组205例,联合应用组300例。氯吡格雷组二磷酸腺苷(ADP)途径血小板抑制率低于阿司匹林组花生四烯酸(AA)途径的抑制率(P<0.05);阿司匹林组AA途径诱导的血小板抑制率显著低于联合应用组( P<0.05);氯吡格雷组ADP诱导的血小板抑制率显著低于联合应用组(P<0.05)。结论常规剂量阿司匹林抗血小板作用优于常规剂量氯吡格雷,阿司匹林与氯吡格雷联合应用抗血小板具有协同作用。
目的:採用Meta分析方法分析阿司匹林、氯吡格雷及兩者聯閤應用抗血小闆作用的效果。方法採用Meta分析方法,檢索MEDLINE、EMbase、Cochrance臨床對照試驗資料庫、中國生物醫學文獻數據庫、中國學術期刊全文數據庫、維普數據庫中相關文獻,收集所有關于以血栓彈力圖評價阿司匹林及氯吡格雷抗血小闆作用的研究文獻。應用RevMan5.2軟件對阿司匹林及氯吡格雷抗血小闆作用進行分析。結果共納入5篇病例對照研究,其中包括阿司匹林組206例,氯吡格雷組205例,聯閤應用組300例。氯吡格雷組二燐痠腺苷(ADP)途徑血小闆抑製率低于阿司匹林組花生四烯痠(AA)途徑的抑製率(P<0.05);阿司匹林組AA途徑誘導的血小闆抑製率顯著低于聯閤應用組( P<0.05);氯吡格雷組ADP誘導的血小闆抑製率顯著低于聯閤應用組(P<0.05)。結論常規劑量阿司匹林抗血小闆作用優于常規劑量氯吡格雷,阿司匹林與氯吡格雷聯閤應用抗血小闆具有協同作用。
목적:채용Meta분석방법분석아사필림、록필격뢰급량자연합응용항혈소판작용적효과。방법채용Meta분석방법,검색MEDLINE、EMbase、Cochrance림상대조시험자료고、중국생물의학문헌수거고、중국학술기간전문수거고、유보수거고중상관문헌,수집소유관우이혈전탄력도평개아사필림급록필격뢰항혈소판작용적연구문헌。응용RevMan5.2연건대아사필림급록필격뢰항혈소판작용진행분석。결과공납입5편병례대조연구,기중포괄아사필림조206례,록필격뢰조205례,연합응용조300례。록필격뢰조이린산선감(ADP)도경혈소판억제솔저우아사필림조화생사희산(AA)도경적억제솔(P<0.05);아사필림조AA도경유도적혈소판억제솔현저저우연합응용조( P<0.05);록필격뢰조ADP유도적혈소판억제솔현저저우연합응용조(P<0.05)。결론상규제량아사필림항혈소판작용우우상규제량록필격뢰,아사필림여록필격뢰연합응용항혈소판구유협동작용。
Objective To analyze the differences in the antiplatelet effects of aspirin , clopidogrel and joint application by Meta-analysis.Methods According to Meat-analysis, MEDLINE, EMbase, CCTR, CBMdisc, CNKI and VIP data-base were searched for the related randomized controlled trials (RCTs).Analysis was performed by RevMan5.2 software to study the antiplatelet effects of aspirin and clopidogrel .Results Five case-control studies were included , containing 206 cases in the aspirin group , 205 cases in the clopidogrel group and 300 cases in dual-therapy group .The platelet inhibition rate of clopidogrel group ADP ( Adenosine diphosphate ) pathway was significantly lower than that of aspirin group AA (Arachidonic acid) pathway (P<0.05); the platelet inhibition rate of aspirin group AA pathway was significantly lower than that of dual-therapy group (P<0.05);the platelet inhibition rate of clopidogrel group ADP pathway was significantly lower than that of dual-therapy group (P<0.05).Conclusions The antiplatelet effect of regular dose of aspirin is better than that of clopidogrel .Aspirin and clopidogrel have synergistic antiplatelet effect .